Dialysis News and Research

Latest Dialysis News and Research

Fresenius Medical Care to acquire Euromedic's dialysis service business

Fresenius Medical Care AG & Co. KGaA, the world's largest provider of dialysis products and services, today announced the signing of a purchase agreement to acquire International Dialysis Centers ("IDC"), Euromedic International's ("Euromedic") dialysis service business.

4 Jan 2011

Patients unresponsive to anti-anemia drug have higher risk of cardiovascular disease, death

Patients with diabetes, kidney disease and anemia who don't respond to treatment with an anti-anemia drug have a higher risk of cardiovascular disease or death, researchers at UT Southwestern Medical Center have found.

28 Dec 2010

MCP-1 protein may contribute to failure of AV fistulas created for vascular access in dialysis patients

A protein implicated in the development of vascular diseases may also contribute to the failure of arteriovenous (AV) fistulas created for vascular access in dialysis patients, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN).

23 Dec 2010

Renal Advantage, Liberty Dialysis announce deal closure

Renal Advantage and Liberty Dialysis, which last month agreed to combine to form the third largest provider of dialysis services in the U.S., today announced that they have closed their deal. The transaction – terms of which were not disclosed – was completed on December 17, 2010. The combined organization has 5,300 employees serving more than 19,000 patients in 260 locations in 32 states.

23 Dec 2010

Liberty Dialysis and Renal Advantage to form the third largest dialysis provider in the U.S.

Liberty Dialysis and Renal Advantage today announced that the deal to form the 3rd largest dialysis provider in the U.S. has closed. The transaction was completed on December 17, 2010. The new company has 5,300 employees serving more than 19,000 patients in 260 locations in 32 states.

23 Dec 2010

FDA approves Novartis' Amturnide for treatment of high blood pressure

Today Novartis announced that the US Food and Drug Administration (FDA) approved Amturnide (aliskiren, amlodipine and hydrochlorothiazide) tablets for the treatment of high blood pressure. Amturnide combines the only approved direct renin inhibitor worldwide, Tekturna (aliskiren), with the widely used calcium channel blocker amlodipine and the diuretic hydrochlorothiazide (HCTZ).

23 Dec 2010

Researchers identify class of drugs that can promote RBC formation in anemic patients

By determining how corticosteroids act to promote red blood cell progenitor formation, Whitehead Institute researchers have identified a class of drugs that may be beneficial in anemias, including those resulting from trauma, sepsis, malaria, kidney dialysis, and chemotherapy.

22 Dec 2010

Mesa Labs announces acquisition of Apex's biological indicators business

Mesa Laboratories, Inc., a Lakewood, Colorado based manufacturer of electronic instruments and disposables today announced the acquisition of the biological indicators business of Apex Laboratories, Inc., a North Carolina based company. The acquisition of the Apex business is expected to be immediately accretive to Mesa's earnings per share.

22 Dec 2010

FMCNA recommends dialysis patients to take precautions during severe weather

Fresenius Medical Care North America, the nation's leading network of dialysis facilities, reminds dialysis patients to take precautions now so they are not caught off guard when severe weather hits in their home community.

21 Dec 2010

Exosomes derived from lymphoma, colorectal cancer patients circulated through Aethlon's Hemopurifier

Aethlon Medical, Inc., the pioneer in developing therapeutic filtration devices to address infectious disease and cancer, announced today that it has demonstrated the ability to capture immunosuppressive exosomes derived from individuals with lymphoma and colorectal cancer.

20 Dec 2010

UIC introduces robotic kidney transplantation surgery for obese recipients

Surgeons at the University of Illinois Medical Center at Chicago are the first to offer robotic kidney transplantation to morbidly obese patients and report fewer complications among this high risk population.

17 Dec 2010

Study: Natural high hemoglobin levels safe for kidney disease patients on dialysis

Naturally occurring high hemoglobin levels are safe for kidney disease patients on dialysis, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology.

17 Dec 2010

State roundup: Minn. to add more adults to Medicaid; Mass. Gov. seeks savings in pensions and health care costs; Ariz. bishop and hospital spar over control

Minnesota can add 95,000 low-income adults to its Medicaid rolls, vastly improving their medical care, at no additional cost to the state, two officials at the state Department of Human Services told legislators Tuesday (Wolfe, 12/15).

16 Dec 2010

Davita launches online tool for dialysis patients

DaVita Inc., a leading provider of kidney care services for those diagnosed with chronic kidney disease and end stage renal disease, today announced the launch of MyDaVita, an online tool intended to help patients connect with one another for friendship, support and educational information.

15 Dec 2010

Research: Kidney disease caused by autoimmune disease lupus may be twice as lethal in children

Kidney disease caused by the autoimmune disease lupus may be twice as lethal in children as kidney disease caused by other disorders, according to research led by Johns Hopkins Children's Center investigators.

13 Dec 2010

In effort to curb preventable ICU infections, new reporting requirement kicks in Jan. 1

A new rule will require hospitals to report infections the follow a patient's treatment in intensive-care units. Meanwhile, a new study finds mortality risks related to dialysis are higher at for-profit chains.

10 Dec 2010

Low phosphate diets may increase dialysis patients' risk of premature death

Doctors often ask kidney disease patients on dialysis to limit the amount of phosphate they consume in their diets, but this does not help prolong their lives, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology.

10 Dec 2010

Mortality is higher in for-profit than non-profit dialysis centers, says study

If you need dialysis for advanced kidney disease, where you get it could make a big difference. A large study found that patients in certain large chain facilities are significantly more likely to die than those treated elsewhere. Mortality was also higher in for-profit than non-profit dialysis centers.

9 Dec 2010

Study comparing subcutaneous, intravenous administration of VELCADE in relapsed MM patients presented at ASH

Millennium: The Takeda Oncology Company today reported results from a randomized, international Phase III clinical trial comparing subcutaneous and intravenous administration of VELCADE (bortezomib) in patients with relapsed multiple myeloma. These data were presented at the 52nd annual meeting of the American Society of Hematology, held December 4-7 in Orlando, Florida.

8 Dec 2010

Three abstracts on Defibrotide presented at ASH Annual Meeting

Gentium S.p.A. today announced that three abstracts on Defibrotide were presented at the 52nd Annual Meeting and Exposition of the American Society of Hematology held at the Orange County Convention Center in Orlando, Florida, December 4-7, 2010.

8 Dec 2010

Dialysis News and Research

Latest Dialysis News and Research

Fresenius Medical Care to acquire Euromedic's dialysis service business

Patients unresponsive to anti-anemia drug have higher risk of cardiovascular disease, death

MCP-1 protein may contribute to failure of AV fistulas created for vascular access in dialysis patients

Renal Advantage, Liberty Dialysis announce deal closure

Liberty Dialysis and Renal Advantage to form the third largest dialysis provider in the U.S.

FDA approves Novartis' Amturnide for treatment of high blood pressure

Researchers identify class of drugs that can promote RBC formation in anemic patients

Mesa Labs announces acquisition of Apex's biological indicators business

FMCNA recommends dialysis patients to take precautions during severe weather

Exosomes derived from lymphoma, colorectal cancer patients circulated through Aethlon's Hemopurifier

UIC introduces robotic kidney transplantation surgery for obese recipients

Study: Natural high hemoglobin levels safe for kidney disease patients on dialysis

State roundup: Minn. to add more adults to Medicaid; Mass. Gov. seeks savings in pensions and health care costs; Ariz. bishop and hospital spar over control

Davita launches online tool for dialysis patients

Research: Kidney disease caused by autoimmune disease lupus may be twice as lethal in children

In effort to curb preventable ICU infections, new reporting requirement kicks in Jan. 1

Low phosphate diets may increase dialysis patients' risk of premature death

Mortality is higher in for-profit than non-profit dialysis centers, says study

Study comparing subcutaneous, intravenous administration of VELCADE in relapsed MM patients presented at ASH

Three abstracts on Defibrotide presented at ASH Annual Meeting

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Empowering genomics research with cloud-based innovation

Dialysis News and Research

Latest Dialysis News and Research

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Empowering genomics research with cloud-based innovation

Newsletters you may be interested in